Release Date: 24/02/15 14:19 Summary: Appendix 4D and Interim Financial Report Price Sensitive: Yes Download Document 2.41MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%